Shandong Jincheng Pharmaceutical and Chemical Co Ltd Working Capital to Net Assets Ratio
Shandong Jincheng Pharmaceutical and Chemical Co Ltd working capital to net assets ratio. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Working Capital to Net Assets ratio of 24.3% as of March 2026. Working capital of CN¥919.64 Million (current assets of CN¥2.17 Billion minus current liabilities of CN¥1.26 Billion) is measured against net assets of CN¥3.78 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Working capital to net assets ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 24.3%, reflecting working capital of CN¥919.64 Million against net assets of CN¥3.78 Billion CNY. Explore investment intensity of Shandong Jincheng Pharmaceutical and Che to see how much of total assets are deployed in long-term investments.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Working Capital to Net Assets Ratio by Year (2008–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Shandong Jincheng Pharmaceutical and Che balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 23.2% | CN¥863.75 Million | CN¥3.72 Billion | CN¥2.09 Billion | CN¥1.22 Billion | ▼ -3.6 pp |
| 2024 | 26.8% | CN¥1.03 Billion | CN¥3.83 Billion | CN¥2.26 Billion | CN¥1.23 Billion | ▲ +6.5 pp |
| 2023 | 20.3% | CN¥768.96 Million | CN¥3.78 Billion | CN¥2.37 Billion | CN¥1.60 Billion | ▲ +3.7 pp |
| 2022 | 16.6% | CN¥607.21 Million | CN¥3.66 Billion | CN¥2.31 Billion | CN¥1.70 Billion | ▼ -4.4 pp |
| 2021 | 21.0% | CN¥722.83 Million | CN¥3.44 Billion | CN¥2.14 Billion | CN¥1.42 Billion | ▼ -9.9 pp |
| 2020 | 30.9% | CN¥1.07 Billion | CN¥3.47 Billion | CN¥2.22 Billion | CN¥1.15 Billion | ▲ +6.2 pp |
| 2019 | 24.8% | CN¥1.01 Billion | CN¥4.08 Billion | CN¥2.19 Billion | CN¥1.18 Billion | ▲ +1.5 pp |
| 2018 | 23.3% | CN¥953.26 Million | CN¥4.09 Billion | CN¥1.88 Billion | CN¥928.43 Million | ▲ +0.9 pp |
| 2017 | 22.5% | CN¥884.09 Million | CN¥3.94 Billion | CN¥1.73 Billion | CN¥844.41 Million | ▼ -7.0 pp |
| 2016 | 29.5% | CN¥443.08 Million | CN¥1.50 Billion | CN¥1.12 Billion | CN¥681.88 Million | ▲ +2.3 pp |
| 2015 | 27.2% | CN¥356.30 Million | CN¥1.31 Billion | CN¥990.35 Million | CN¥634.06 Million | ▲ +6.6 pp |
| 2014 | 20.6% | CN¥229.78 Million | CN¥1.12 Billion | CN¥842.12 Million | CN¥612.34 Million | ▼ -8.2 pp |
| 2013 | 28.7% | CN¥293.58 Million | CN¥1.02 Billion | CN¥808.34 Million | CN¥514.76 Million | ▼ -14.0 pp |
| 2012 | 42.8% | CN¥417.07 Million | CN¥975.57 Million | CN¥865.15 Million | CN¥448.08 Million | ▼ -4.7 pp |
| 2011 | 47.5% | CN¥455.15 Million | CN¥958.84 Million | CN¥841.50 Million | CN¥386.35 Million | ▲ +58.4 pp |
| 2010 | -11.0% | CN¥-41.19 Million | CN¥375.33 Million | CN¥494.40 Million | CN¥535.60 Million | ▼ -8.2 pp |
| 2009 | -2.8% | CN¥-7.85 Million | CN¥281.53 Million | CN¥363.19 Million | CN¥371.04 Million | ▲ +4.5 pp |
| 2008 | -7.3% | CN¥-15.76 Million | CN¥216.49 Million | CN¥365.91 Million | CN¥381.67 Million | — |